학술논문

Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial
Document Type
Article
Source
In: The Lancet. (The Lancet, 2 September 2023, 402(10404):775-785)
Subject
Language
English
ISSN
1474547X
01406736